Dimensional Fund Advisors
ELDN icon

Dimensional Fund Advisors’s Eledon Pharmaceuticals ELDN Stock Holding History

Dimensional Fund Advisors’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.12M Buy
538,738
+471,657
+703% +$1.72M ﹤0.01% 2730
2026
Q1 		$204K Sell
67,081
-48,601
-42% -$114K ﹤0.01% 3067
2025
Q4 		$175K Sell
115,682
-19,079
-14% -$45.4K ﹤0.01% 3102
2025
Q3 		$349K Sell
134,761
-1,695
-1% -$4.96K ﹤0.01% 3046
2025
Q2 		$370K Buy
136,456
+20,281
+17% +$60.8K ﹤0.01% 3042
2025
Q1 		$394K Buy
116,175
+93,142
+404% +$383K ﹤0.01% 3029
2024
Q4 		$94.9K Sell
23,033
-11,190
-33% -$44.1K ﹤0.01% 3246
2024
Q3 		$85.2K Buy
34,223
+3,990
+13% +$10.7K ﹤0.01% 3252
2024
Q2 		$79.8K Buy
+30,233
New +$72.2K ﹤0.01% 3273
2023
Q2 		– Sell
-17,954
Closed -$42.4K – 3492
2023
Q1 		$42.4K Buy
+17,954
New +$48.1K ﹤0.01% 3396
2022
Q3 		$50K Buy
+17,950
New +$57.2K ﹤0.01% 3404

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCM
Catalio Capital Management New York $532M AUM 171.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ZP
Zimmer Partners New York $4.34B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors's ELDN Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Eledon Pharmaceuticals (ELDN) stake by 703% in Q2 2026, buying an estimated $1.72M and bringing the position to 538,738 shares worth $2.12M. The position accounts for ﹤0.01% of the portfolio, ranked #2730.

Dimensional Fund Advisors first reported a position in ELDN in Q3 2022 and has held it in 11 quarters since. 160 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

  • Dimensional Fund Advisors held 538,738 shares of Eledon Pharmaceuticals worth $2.12M as of Q2 2026.
  • Dimensional Fund Advisors bought 471,657 Eledon Pharmaceuticals shares in Q2 2026, an estimated $1.72M.
  • Eledon Pharmaceuticals made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2730 holding.
  • Dimensional Fund Advisors first reported a position in Eledon Pharmaceuticals in Q3 2022 and has held it in 11 quarters since.
  • 160 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.